SPIN2A is a nuclear protein involved in cell cycle regulation and apoptosis resistance. Primary function: SPIN2A exhibits H3K4me3-binding activity 1, indicating a role as a histone reader that may regulate transcription. The protein functions as a nuclear anti-apoptotic factor that provides substantial protection from growth factor withdrawal-induced apoptosis in myeloid progenitors, with overexpression increasing cells in G2/M phase 2. Mechanism: SPIN2A localizes to the nucleus where its anti-apoptotic and cell cycle regulatory activities are functionally dependent 2. It associates with other proteins including Hsp70 during cellular stress responses 3. Disease relevance: SPIN2A is identified as a strong candidate for Parkinson's disease susceptibility, with variants near SPIN2A serving as expression quantitative trait loci in a genome-wide X-chromosome X study of an African cohort; notably, SPIN2A is highly expressed in brain and nerve tissues 4. Clinical significance: The histone-binding capacity combined with roles in cell cycle progression and apoptosis resistance suggests SPIN2A may be therapeutically relevant in neurodegenerative diseases, though direct functional validation in PD pathogenesis remains insufficient.